Pneumococcal

Pharmacy-driven education can increase immunization acceptance among hospitalized patients refusing flu or pneumococcal vaccination upon admission.

Pneumococcal immunization recommendations have changed multiple times in previous years, but the rationale behind the new recommendations may not be clearly understood.

The Advisory Committee on Immunization Practices recently updated the recommended interval between the 13-valeant pneumococcal conjugate vaccine and the 23-valeant pneumococcal polysaccharide vaccine in low-risk elderly patients.

Influenza boosts the ability of pneumococci to cause middle ear and throat infections.

A reduction in pediatric health care visits related to otitis media between 2001 and 2011 appears to be due to uptake of the pneumococcal conjugate vaccine, according to the results of a new study.